Generics - Financial, South America

Filter

Current filters:

FinancialSouth America

Popular Filters

10 billion real to be invested in Brazil’s production of biotech drugs by 2016

10 billion real to be invested in Brazil’s production of biotech drugs by 2016

27-01-2014

Brazil's Development Bank (BNDS) plans to invest up to 10 billion real ($4.2 billion) in the production…

BiotechnologyBrazilFinancialGenericsHypermarcasMarkets & MarketingProductionSanofiSouth America

Brazilian pharmachemical sector discussed at parliamentary public hearing

31-10-2013

Fiocruz's Production and Innovation in Health vice-president Jorge Bermudez highlighted the importance…

FinancialGenericsProductionSouth America

Brazil interested in investing $4.5 Billion in Ukraine, including pharma

19-11-2012

Brazil has submitted to Ukrainian authorities $4.5 billion worth of investment proposals. "We want to…

DiabetesEuropeFinancialGenericsPharmaceuticalProductionSouth America

Venezuelan govt increasing control over pharmaceutical sector

14-08-2012

Venezuela's national government has changed its policy with regard to the pharmaceutical sector. This…

FinancialGenericsPharmaceuticalPricingRegulationSouth America

Brazil takes control over its pharma market, but generics threaten to cut future profits

27-06-2012

Continuous support from the government is helping the Brazilian pharmaceutical market to expand at a…

FinancialGenericsMarkets & MarketingPharmaceuticalSouth America

Valeant Pharma to acquire assets in Mexico; Mylan invests in Ireland

19-04-2012

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says it has signed an…

Atlantis PharmaEuropeFinancialGenericsMergers & AcquisitionsMylan LaboratoriesSouth AmericaValeant Pharmaceuticals

Back to top